|Articles|August 1, 2000

August 2000
Volume 6
Issue 8

The Community Assessment Risk Screen (CARS): Identifying Elderly Persons at Risk for Hospitalization or Emergency Department Visit

Author(s)Paul Shelton, EdD, Mark A. Sager, MD, Cheryl Schraeder, PhD

Download PDF: The Community Assessment Risk Screen (CARS): Identifying Elderly Persons at Risk for Hospitalization or Emergency Department Visit

Articles in this issue

almost 26 years ago

Article

What Price an Additional Day of Life? A Cost-Effectiveness Study of Case Management

almost 26 years ago

Article

Use of Randomized Controlled Trials in Organizational Decision Making: A Cost-Minimization Approach

almost 26 years ago

Article

Cost Effectiveness of Rabeprazole Versus Generic Ranitidine for Symptom Resolution in Patients with Erosive Esophagitis

almost 26 years ago

Article

Medicare Disenrollment and Selective Use of Medical Care: Osteoarthritis-Related Joint Replacement

almost 26 years ago

Article

Proton Pump Inhibitors: Cost-Effective Agents for Management of Reflux-Induced Esophagitis

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

The Community Assessment Risk Screen (CARS): Identifying Elderly Persons at Risk for Hospitalization or Emergency Department Visit

Articles in this issue

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Trending on AJMC

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year

GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis

Oral Orforglipron Added to Basal Insulin Cuts HbA1c in Type 2 Diabetes

The Emerging Role of Factor XIa Inhibition in Stroke Prevention